Holen Sie sich die Stockscreener-App
18.93
18.39%
2.94
Handel nachbörslich:
18.56
-0.37
-1.95%
Schlusskurs vom Vortag:
$15.99
Offen:
$16.3
24-Stunden-Volumen:
285.31K
Relative Volume:
2.02
Marktkapitalisierung:
$177.76M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-81.17M
KGV:
-1.8679
EPS:
-10.1344
Netto-Cashflow:
$-82.84M
1W Leistung:
+20.57%
1M Leistung:
+48.94%
6M Leistung:
-34.90%
1J Leistung:
-47.94%
1-Tages-Spanne:
$16.25
$19.73
1-Wochen-Bereich:
$14.15
$19.73
52-Wochen-Spanne:
$10.29
$98.00
Korro Bio Inc Stock (KRRO) Company Profile
Firmenname
Korro Bio Inc
Sektor
Branche
Telefon
617-468-1999
Adresse
60 FIRST STREET, CAMBRIDGE
Vergleichen Sie KRRO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
18.93 | 150.15M | 0 | -81.17M | -82.84M | -10.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-16 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-01-10 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-21 | Eingeleitet | Raymond James | Strong Buy |
| 2024-08-14 | Eingeleitet | William Blair | Outperform |
| 2024-03-28 | Bestätigt | H.C. Wainwright | Buy |
| 2024-02-27 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-12-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-11-10 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-15 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2023-02-13 | Herabstufung | Cowen | Outperform → Market Perform |
| 2021-09-22 | Herabstufung | Goldman | Buy → Neutral |
| 2021-01-27 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-12-22 | Eingeleitet | B. Riley Securities | Buy |
| 2020-07-14 | Eingeleitet | Oppenheimer | Outperform |
| 2020-05-18 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-10-28 | Eingeleitet | Cowen | Outperform |
| 2019-10-28 | Eingeleitet | Goldman | Buy |
| 2019-10-28 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Korro Bio Inc Aktie (KRRO) Neueste Nachrichten
Is Korro Bio Inc. showing signs of accumulationJuly 2025 Selloffs & Free Fast Gain Swing Trade Alerts - Newser
Using AI based signals to follow Korro Bio Inc.July 2025 Recap & High Conviction Buy Zone Picks - Newser
Will Korro Bio Inc. continue its uptrendWeekly Stock Recap & AI Driven Price Predictions - Newser
Korro Bio stock price target lowered to $90 at H.C. Wainwright - Investing.com Australia
Is now a turning point for Korro Bio Inc.Trade Volume Summary & Stock Market Timing Techniques - Newser
Korro Bio Inc. stock trend outlook and recovery path2025 Key Lessons & Step-by-Step Trade Execution Guides - Newser
Korro Bio stock price target lowered to $147 at Raymond James - Investing.com
Blair William & Co. IL Buys 3,335 Shares of Korro Bio, Inc. (NASDAQ:KRRO) - Defense World
How Korro Bio Inc. stock performs during market volatilityJuly 2025 Levels & Weekly High Conviction Ideas - Newser
Order flow analysis tools used on Korro Bio Inc.2025 Retail Activity & Accurate Buy Signal Notifications - Newser
Analyzing net buyer seller activity in Korro Bio Inc.Trade Entry Report & AI Enhanced Trading Alerts - Newser
What institutions are buying Korro Bio Inc. stock nowJuly 2025 Chart Watch & Daily Market Momentum Tracking - Newser
Korro Bio Advances RNA Editing Programs in Q2 2025 - TipRanks
Korro Bio Inc. stock outlook for YEARStrong Buy Signal Summary with Entry Zone - Newser
Analyzing net buyer seller activity in Korro Bio Inc. [July 2025 Price Swings]Community Trade Idea Sharing - Newser
Korro Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Korro Bio, Inc. SEC 10-Q Report - TradingView
Korro Reports Second Quarter 2025 Financial Results and Provides Business Updates - The Manila Times
Can momentum traders help lift Korro Bio Inc.Watchlist Generator With Real-Time Entry - Newser
Is Korro Bio Inc. being accumulated by smart moneyFree Stock Trading Courses - mustnews.co.kr
What makes Korro Bio Inc. stock price move sharplyFree Growth Based Stock Signal Screener - Newser
What risks could impact Korro Bio Inc. stock performanceTrade Flow Monitor with Volume Tracker - Newser
What makes Korro Bio Inc. stock attractive to long term investorsFree Wealth Building Stock Market Ideas - Newser
How moving averages guide Korro Bio Inc. tradingHigh Conviction Stock Long-Term Summary - Newser
Sectors Driving Future Growth for Korro Bio Inc. StockShort Term Profit Strategy with Entry Cues - Newser
Developing predictive dashboards with Korro Bio Inc. dataDay Trading Setup Forecast with Trend Model - Newser
Will Korro Bio Inc. stock split in the near futureFree High Yield Stocks With Buy Confirmation - Newser
Korro Bio (KRRO) Expected to Announce Earnings on Tuesday - Defense World
Korro Bio KRRO Q2 2025 Earnings Preview Upside Anticipated on Strategic Developments - AInvest
Will Korro Bio Inc. outperform the marketRisk Balanced Picks for Safer Trading - Newser
Candlestick signals on Korro Bio Inc. stock todayFree AI Based High Gain Watchlist Scanner - Newser
Will Korro Bio Inc. stock go up soonFree Trade Setups With AI Powered Filters - Newser
Intraday pattern recognizer results for Korro Bio Inc.Algorithmic Prediction of Market Breakouts - Newser
Bank of New York Mellon Corp Boosts Position in Korro Bio, Inc. (NASDAQ:KRRO) - Defense World
Finanzdaten der Korro Bio Inc-Aktie (KRRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):